Cannabis Bioscience International Holdings (CBIH) Short term Debt (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Short term Debt across 4 years of filings, most recently posting $14592.0 for Q1 2026.

• Short term Debt for Q1 2026 came in at $14592.0, down 80.07% year-over-year; the trailing twelve-month figure through Feb 2026 was $14592.0 (down 80.07% YoY), and the FY2025 annual result was $14592.0, changed N/A from the prior year.
• Short term Debt came in at $14592.0 for Q1 2026 at Cannabis Bioscience International Holdings, roughly flat from $14592.0 in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $73228.0 in Q1 2025 to a low of $7054.0 in Q1 2024.
• The 4-year median for Short term Debt is $14592.0 (2023), against an average of $19152.8.
• Across the five-year window, Short term Debt surged 938.11% in 2025 and plunged 80.07% in 2026, its largest moves.
• Cannabis Bioscience International Holdings' Short term Debt stood at $12079.0 in 2023, then increased by 20.8% to $14592.0 in 2024, then changed by 0.0% to $14592.0 in 2025, then changed by 0.0% to $14592.0 in 2026.
• The last three Short term Debt figures came in at $14592.0 (Q1 2026), $14592.0 (Q4 2025), and $14592.0 (Q2 2025), per Business Quant data.